Literature DB >> 3407839

Larvicidal effect of albendazole against Angiostrongylus cantonensis in mice.

K P Hwang1, E R Chen.   

Abstract

Mice were infected with 50 third stage larvae of Angiostrongylus cantonensis and treated orally with albendazole (Zentel) in dosages of 5, 10, and 25 mg/kg/day begun 5, 10, or 15 days post-infection for 7, 14, or 21 consecutive days. The mice in each group were killed 3 days after cessation of treatment and the brains examined for parasites. Worms were recovered from the brains of all mice treated for 7 days, but recoveries from treated mice were significantly lower than from controls. Worm reduction was nearly 100% in mice treated for 14 days when treatment was initiated 5 and 10 days post-infection. Worms were found in the brain of mice treated for 14 days when treatment began at 15 and 20 days, but recovery rates were significantly lower than in controls. Similar results were obtained in animals treated for 21 days. Worm reduction rates were lower in animals given 5 mg/kg/day, but there was no significant difference in animals given higher dosages. Albendazole was effective in the treatment of A. cantonensis in mice when given within 15 days post-infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407839     DOI: 10.4269/ajtmh.1988.39.191

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis.

Authors:  Suthipun Jitpimolmard; Kittisak Sawanyawisuth; Nimit Morakote; Athasit Vejjajiva; Montien Puntumetakul; Kanokwan Sanchaisuriya; Wongwiwat Tassaneeyakul; Wichittra Tassaneeyakul; Narumanas Korwanich
Journal:  Parasitol Res       Date:  2006-12-20       Impact factor: 2.289

Review 2.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

3.  A severe case of Angiostrongylus eosinophilic meningitis with encephalitis and neurologic sequelae in Hawa'i.

Authors:  Edward Kwon; Tomas M Ferguson; Sarah Y Park; Augustina Manuzak; Yvonne Qvarnstrom; Stephen Morgan; Paul Ciminera; Gerald S Murphy
Journal:  Hawaii J Med Public Health       Date:  2013-06

4.  Neuroangiostrongyliasis: The "Subarachnoid Phase" and Its Implications for Anthelminthic Therapy.

Authors:  Paul Prociv; Megan Turner
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

5.  Permissibility of Mongolian gerbil for Angiostrongylus cantonensis infection and utility of this animal model for anthelmintic studies.

Authors:  Yongfang Wei; Qing Hong; Daixiong Chen; Chenjie Liang; Haiying Liu; Xiaodong Luo; Xunmin Zhu
Journal:  Parasitol Res       Date:  2014-02-21       Impact factor: 2.289

6.  The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.

Authors:  K P Lan; C J Wang; S C Lai; K M Chen; S S Lee; J D Hsu; H H Lee
Journal:  Parasitol Res       Date:  2004-06-04       Impact factor: 2.289

7.  Combined treatment with interleukin-12 and mebendazole lessens the severity of experimental eosinophilic meningitis caused by Angiostrongylus cantonensis in ICR mice.

Authors:  Wen-Yuan Du; Jiunn-Wang Liao; Chia-Kwung Fan; Kua-Eyre Su
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 8.  Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.

Authors:  L Monteiro; J Almeida-Pinto; A Stocker; M Sampaio-Silva
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

9.  A blind passenger: a rare case of documented seroconversion in an Angiostrongylus cantonensis induced eosinophilic meningitis in a traveler visiting friends and relatives.

Authors:  Tobias Brummaier; Sonja Bertschy; Kornelius Arn; Thomas Treumann; Marie-Therese Ruf; Beatrice Nickel; Daniel H Paris; Andreas Neumayr; Johannes Blum
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-04-15

10.  Guidelines for the diagnosis and treatment of neuroangiostrongyliasis: updated recommendations.

Authors:  Vernon Ansdell; Kenton J Kramer; Jourdan K McMillan; William L Gosnell; Gerald S Murphy; B C Meyer; Elizabeth U Blalock; Johnnie Yates; Louis Lteif; Olivia A Smith; Marian Melish
Journal:  Parasitology       Date:  2020-07-30       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.